opioid crisis
Coverage of opioid crisis in the Nexus archive.
- Did US drug agents allow lethal fentanyl to hit New Mexico’s streets?
A whistleblower claims DEA agents allowed large quantities of fentanyl pills into Albuquerque to facilitate a larger drug-trafficking bust, raising questions about potential legal violations and public safety risks amid the city's ongoing opioid crisis.
- Did US drug agents allow lethal fentanyl to hit New Mexico’s streets?
A whistleblower alleges that DEA agents allowed large quantities of fentanyl pills to enter Albuquerque, New Mexico, in an attempt to secure a larger drug-trafficking bust. The claim, detailed in an Associated Press story, highlights concerns about public safety amid Albuquerque's ongoing opioid crisis.
- 11th Circuit skirts dispute over insurers defending pharmacies from opioid crisis lawsuits
The 11th Circuit declined to resolve whether insurers must defend pharmacies in opioid crisis lawsuits, instead certifying the issue to Georgia and Florida's Supreme Courts due to ambiguity in state insurance law. Insurers argue their policies exclude coverage for economic losses tied to the opioid epidemic, while the lawsuits allege pharmacy practices caused bodily injuries like addiction and overdose.
- Fentanyl Dealer Sentenced to More Than a Decade In Federal Prison
A fentanyl dealer has been sentenced to more than a decade in federal prison for drug trafficking offenses. The conviction represents law enforcement efforts to combat the opioid crisis by prosecuting major drug distributors. The substantial prison sentence reflects the severity of fentanyl-related crimes in the federal justice system.
- Putnam County Man Pleads Guilty to Fentanyl Crimes
A man from Putnam County has pleaded guilty to fentanyl-related crimes. The case involves charges related to the distribution or possession of fentanyl, a highly potent opioid. This guilty plea represents a law enforcement success in combating the opioid crisis.
- Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case
Purdue Pharma, the maker of OxyContin, is being dissolved and replaced by a new company focused on addressing the opioid crisis as part of a legal settlement. A federal judge approved a criminal sentence to resolve a DOJ investigation, finalizing the settlement.
- Are You Waiting for Opioid Settlement Money From Purdue, Mallinckrodt or Endo? Get in Touch.
ProPublica and The Philadelphia Inquirer are investigating how opioid victims have been compensated by trusts funded by Purdue, Mallinckrodt, and Endo. The article seeks input from individuals seeking payment for harm caused by these companies' drugs.
- Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case
Purdue Pharma is set to forfeit $225 million to the US Justice Department as part of a 2020 settlement resolving federal civil and criminal investigations over its role in the opioid crisis. The Sackler family will pay state, local, and tribal governments, individual victims, and others under the agreement.
- Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Purdue Pharma is set to be sentenced to a $225 million criminal penalty, clearing the way for a $7 billion settlement from the Sackler family to address the opioid crisis. The settlement, approved in 2020, resolves federal and state lawsuits over Purdue's role in aggressively marketing OxyContin, contributing to the opioid epidemic.
- The red-state psychedelic
The article highlights an individual's initiative to address the opioid crisis using psychedelic therapy, focusing on red states where such treatments are gaining attention. It emphasizes a novel approach to treating addiction through controlled psychedelic experiences.